Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Steve, No calls to IR. No telling us all what we want to hear when talking “Off the record”. Filings, PRs, agreements, financing is all that matters.
Time for Curative to deliver.
Student Steve,
Things have been very quiet for the past few months. Can the shareholders get an update on progress in Japan, patents, studies, financing along with some reliable timelines?
Thanks in advance
He ain’t Schuman. He can’t even spell Schuman’s name correctly. Don’t think the conspiracy runs that deep.
Robot, what are you inferring, again. Still you coded J conspiracy?
HEY STUDENT. You and your boys need to tune in here.
Credit for owning it finally. Now get Curative moving.
Fix the Verified Profile
Get Financing Done
Move the AMD Drug Through Trials
Start posting actual dates you’re gonna hit
Tell Paul to start promoting Curative through LinkedIn, Twitter, updating your website, PRs, partnerships…
Time to earn the money that’s you’ll have bled out of everyone’s accounts.
Robot, If you keep accusing what happens if the SEC acts on it? It won’t be just an issue for SotG, the blowback would hit the company hard and probably hurt your chances of hitting three cents assuming they are legit.
Maybe let it all play out. At this point there isn’t much downside to you for just waiting about few quarters.
Personally, I’d like success here for the stock and the drug. This is personal. The odds of me getting AMD in the next 10-15 years is very high. If Curative has a treatment that could help me medically and financially, I’m ready to keep waiting.
I don’t want investors ranting online who prefer to burn it all down in a temper tantrum. Let’s collectively add to the DD so when whales read about Curative, the info we post builds and isn’t a red flag. Let’s see what the situation is in a few more quarters.
So exclusive for the next ~20 years based on it being filed fairly recently. Less development, testing, time to license (if successful) probably means offering to big pharma with renaming 15 years. (Lots of assumptions but the clock is not ticking too fast yet).
Student, is the clock ticking on how long Curative has exclusivity for reformulated Metformin?
@student, is this true?
If we have such a great story to tell about how great this Metformin eye drop could be for AMD patients, how come the founders and advisors with years of industry experience have been unable to make any visible progress month after month after month? Wouldn’t venture money be pouring in with the market potential being so large and Curative having exclusivity?
I get that drug discovery takes time, but we are not stopped with a science problem or hung up in a lengthy clinical trial process. We are stalled for other reasons. Somewhere Curative has a problem of credibility, incompetence or dishonesty (or maybe some combination). On paper, this team should be able to make progress and use their connections to bring in the funding to get things moving, but that has not been happening.
Let’s go already!!
I personally am bullish and want the company to succeed. 30-40 cents sets me up wonderfully. More than that is gravy.
AMD sucks, it is a nightmare. It has affected my family twice. Once with my grandfather going 100% blind, and a second time with an aunt who is getting injections in her eye. WTF? Shots in your eyes, how horrific is that?!?!
So I want drops to work and I want the company to succeed, it matters to me personally. That is why I keep my negative opinions abut the company, its people, its actions to myself. I do not want someone doing DD to read anything but the blue sky potential for the treatment and company. I want some whale to come in and take a chance and try to help fund the next steps to bring the drops further through trials.
Am I delusional, probably. I know the odds here. But in drug development you have to have a wide net cast and the investment needs to be big enough to have the win worth the costs. As an investor, I should have taken my winnings off the table at 21 cents. That was stupid to have gotten that greedy. But I own that choice.
Do a PR that the split is dead. That will get the toxic stench off this company.
My 2.59 million shares vote for no RS. Grow share price organically through results. Do share buy back but never ever another RS.
I should have sold at .20. But I believed in the story of the company and bought into the idea that this was just the beginning. Got greedy. Now I’ve ridden this all the way down watching a quarter of a million bucks get flushed
Why is $CUBT pushing $.022?
Pink Limited Yield sign??? Why?
Student- how long are those exclusive periods typically?
Can someone ask Steve why we uplist and split has taken a year so far?
What does that mean?
When does their letter to Florida say the split is authorized until? Isn’t that deadline coming up soon?
$5.00 says they paint the close back to $.02 to end the year.
Then today should be an interesting day. Lock in gains if you get them because last the bump a couple days ago had no staying power.
Why do I feel like an upcoming pump was just telegraphed??
Only thing I can tell that was different was that “3F” publicly flipped. Maybe he is an influencer?? Hahaha!!
Lucosky and Brookman is my bet as the new $CUBT underwriter.
Three, you have shifted your opinion from being a strong advocate to be super critical to now sounding more optimistic again. Wondering what you’re hearing that is shifting that stance?
Clearly they have spent a ton of time and money on the offering and prepping for uplist. Do they have the clinical trial information to support the financial goals?
What about the quiet period and interpreting that so literally that nothing has been announced keeping shareholders informed all year?
Just trying to see what is going on that has made you less skeptical.
I think Paul is shopping for a different underwriter.
Half true. Still waiting on the pump. Hahaha
That would be a welcome change.
Why would it be canceled? $CUBT management didn’t just wake up and decide to get their $hit together, did they?
Very very quiet.
What makes you think it’s close?
For $CUBT AMD Trial, this is a six week study then about a six week analysis/write up period, correct?
My math says details come out in September. Is that about right?
But they wouldn’t have stuck around
It’s arrogant to assume just because you have heard what you want to hear that nothing is going on. $CUBT will announce what they can when they can. Otherwise they would have pumped this to the moon and cashed out a long time ago.
$CUBT is showing something. Been waiting but that’s the nature of biotech
Conix, thanks for the DM. I don’t pay here so please email “my911voice” on gmail
Indeed!! What makes you float that idea and timing?
Doesn’t get much more quiet. No one seems to be doing much of anything.
For the first time in over 9 months I am actually encouraged about $CUBT.
There would have been no point to write the massive S1 if they didn’t have reason to think it was well worth the effort.
Bottom line is they know the Metformin trials are delivering results that will make it able to monetize.
Let’s see … maybe it’s just my super low IQ talking. That’s probably the source of my delusion.
CUBT Investor Group